-transparent.png){kind=logo}
Clinical validation of the Abbott RealTime High Risk HPV assay according to the guidelines for human papillomavirus DNA test requirements for cervical screening. 2013
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
This study showed that the Abbott RealTime High Risk HPV assay fulfilled cross-sectional clinical equivalence and reproducibility criteria of international consensus guidelines, which indicates that this assay can be considered clinically validated for cervical cancer screening purposes.
Related Publications
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
August 2019,
Virology journal,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
March 2018,
Virology journal,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
December 2014,
Journal of clinical microbiology,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
December 2009,
Journal of medical microbiology,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
November 2013,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
March 2016,
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
May 2020,
BMC cancer,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
May 2012,
Annals of laboratory medicine,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
May 2022,
Journal of translational medicine,
A T Hesselink, and
C J L M Meijer, and
M Poljak, and
J Berkhof, and
F J van Kemenade, and
M L van der Salm, and
M Bogaarts, and
P J F Snijders, and
D A M Heideman
January 2023,
Journal of translational medicine,
